CDH3 and breast cancer: In a model of breast cancer, co-expression of P- and E-cadherin was associated with aggressive high-grade breast carcinomas by P-cadherin-mediated disruption of functional cadherin-catenin complexes, thereby obstructing the E-cadherin tumor-suppressive role [97,102,103,104].